TRM
Truscott Mining Corporation Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 175.00%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Truscott Mining Corp. Ltd. is a mineral exploration company, which engages in exploration and development of poly-metallic systems in the Northern Territory. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-04-18. The firm is engaged in the exploration and development of gold and base metal projects in the Northern Territory. The Company’s Tennant Creek projects are all within 25 kilometers of the regional gold mining center of Tennant Creek, in the Northern Territory. The application of the Company's structural modelling has enabled the identification of eight primary nodes that exhibit similar geological settings to the historical deposits. The company also holds 100% tenure over Westminster, Lyall, Hera, Olympus, and Arcadia projects.
📈 Performance
Price History
+160.00%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.08
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in TRM
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in TRM
N/A
TRM investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in TRM also invest in...
Want more shares? Try these...
Tissue Repair Ltd. is a clinical stage bio pharmaceutical company, which develops advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for further development of related technologies. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-11-18. The firm's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The firm is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.
📊 Share price
$0.26 AUD
🧬 BIOTECHNOLOGY
The Reject Shop Limited is an Australia-based company, which is engaged in retailing of discount variety merchandise. The Company specializes in in curating furniture items that are on surplus clearance and factory rejects due to minor cosmetic defects. It sells a range of furniture items that are brand new but have been rejected due to minor defects or damages during the manufacturing process. These items are sold at a lower price compared to similar products available in the market. Its product categories include dining room, living room, bedroom, outdoor, delivery options, office, luxury goods, homeware and appliance, home decor, electronics, and lighting. Its dining room products include HOVE Oval Dining Table in WALNUT, LORRAINE Outdoor Table in GREY, CHUNGHA Carrara Marble Dining Table with WALNUT Frame, BINNA Dining Table in OAK, and DALMASSE Small V-Frame Square Dining Table in NATURAL. Its luxury products include Louis Vuitton Handbag Preloved and TODS Handbag Preloved.
🙌 Performance (5Yr p.a)
-0.07%
📊 Share price
$2.79 AUD
🛍️ CONSUMER
TRI
TrivarX Ltd. engages in clinical research, product development, and early-stage commercialization of mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.
🙌 Performance (5Yr p.a)
5.45%
📊 Share price
$0.01 AUD
📈 HIGH PRICE GROWTH
🩺 HEALTH CARE
Trajan Group Holdings Ltd. engages in the development and manufacture of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. The firm's products and solutions are used in the analysis of biological, food, and environmental samples. The company has a portfolio and pipeline of technologies which support the move towards decentralized, personalized data-based healthcare. Its segments include Components and Consumables, Capital Equipment and Disruptive Technologies. Components and Consumables segment includes all parts, supplies, components and consumable products across the Company. Capital Equipment segment includes all robotic workflow automation systems, on-line instruments, laboratory instruments and related parts and services. Disruptive Technologies segment includes miniaturized, portable instrumentation, and all products and services related to micro sampling. The firm has approximately seven manufacturing sites across the United States, Australia, Europe and Malaysia.
📊 Share price
$1.01 AUD
🔭 LIFE SCIENCES TOOLS & SERVICES